Skip to main content

Table 3 Effects of FSC-S and FSC-SpEt supplementation on hepatic size and liver function in normal and experimental hypercholesterolemic (HCL) mice

From: A comparative study between Wuweizi seed and its post-ethanol extraction residue in normal and hypercholesterolemic mice

Groups Drug dose (%, w/w) Hepatic weight (g) Hepatic index Serum ALT
activity (U/L)
Normal mice     
ND 1.69 ± 0.06 5.98 ± 0.13 53.70 ± 4.30
ND/FSC-S 9 1.90 ± 0.13 9.32 ± 0.39** 42.83 ± 3.06
ND/FSC-SpEt 9 1.85 ± 0.04* 6.55 ± 0.08** 42.58 ± 3.75
ND/FF 0.05 2.75 ± 0.05** 10.00 ± 0.11** 46.59 ± 4.98
HCL mice     
ND 1.79 ± 0.06 6.11 ± 0.07 50.88 ± 1.30
HCBD 2.07 ± 0.05** 7.12 ± 0.09** 62.00 ± 3.59*
HCBD/FSC-S 3 2.56 ± 0.14## 8.81 ± 0.47## 73.78 ± 6.45
  9 2.87 ± 0.17## 11.28 ± 0.51## 82.63 ± 6.11#
HCBD/FSC-SpEt 3 1.99 ± 0.18 6.95 ± 0.15 71.50 ± 2.99
  9 2.01 ± 0.11 7.37 ± 0.13 63.25 ± 2.55
HCBD/FF 0.05 3.46 ± 0.08## 12.19 ± 0.20## 110.50 ± 13.06##
  1. Experimental details were described in Table 1. Mice were fed with ND and HCBD without or with FSC-S, FSC-SpEt, or FF supplementation. Ten days after supplemetnation, hepatic weight and index, as well as serum alanine aminotransferase (ALT) activity were measured. Hepatic index was estimated from the ratio of its weight to body weight × 100. Values given are the means ± SEM, with n = 10. * P < 0.05, ** P < 0.01 vs ND; # P < 0.05, ## P < 0.01 vs HCBD. Statistical significant differences were determined using a one-way ANOVA followed by Dunnett’s multiple comparisons test or post-hoc analysis